Mark Schoenberg, Chief Medical Officer: UroGen Pharma URGN Sell · Filed 06/24

Trade details

Type: Insider sale
Amount: $350,100
Shares · price: 10,000 sh · $35.01 a share
Held after: 129,763 sh
Stock: UroGen Pharma URGN
Person: Mark SchoenbergChief Medical Officer
Trade date: 26/06/22
Filed: 26/06/24
Days to filing: 2 days

Sold 7.2% of holdings

Share of holding sold: 7.2%

UroGen Pharma trades, last 26 weeks

What else happened in UroGen Pharma around then

Filed or reported within 30 days of the trade day · 05/23~07/22

Mark Schoenberg's recent trades

Mark SchoenbergChief Medical Officer
Planned saleUroGen Pharma
Planned sale
UroGen Pharma
URGN
$38.4K
871 sh
$38.4K
Filed 09/09
Traded 09/08
Mark SchoenbergChief Medical Officer
Planned saleUroGen Pharma
Planned sale
UroGen Pharma
URGN
$2.9M
60,677 sh
$2.9M
Filed 08/20
Traded 08/20
Mark SchoenbergChief Medical Officer
Planned sale10b5-1 planUroGen Pharma
Planned sale10b5-1 plan
UroGen Pharma
URGN
$400K
10,000 sh
$400K
Filed 07/09
Traded 07/09
Mark SchoenbergChief Medical Officer
Planned sale10b5-1 planUroGen Pharma
Planned sale10b5-1 plan
UroGen Pharma
URGN
$350.1K
10,000 sh
$350.1K
Filed 06/22
Traded 06/22
Mark SchoenbergChief Medical Officer
SellUroGen Pharma
Sell
UroGen Pharma
URGN
$142.6K
5,222 sh
$142.6K
Filed 06/09
Traded 06/08